Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.
Ollila TA, Olszewski AJ.
Curr Treat Options Oncol. 2018 Jun 21;19(8):38. doi: 10.1007/s11864-018-0555-8.
How we treat primary central nervous system lymphoma.
Calimeri T, Steffanoni S, Gagliardi F, Chiara A, Ferreri AJM.
ESMO Open. 2021 Aug;6(4):100213. doi: 10.1016/j.esmoop.2021.100213. Epub 2021 Jul 13.
Diffuse large B-cell lymphoma variants: an update.
Sukswai N, Lyapichev K, Khoury JD, Medeiros LJ.
Pathology. 2020 Jan;52(1):53-67. doi: 10.1016/j.pathol.2019.08.013. Epub 2019 Nov 15.
CAR T-cell therapy in large B cell lymphoma.
Boardman AP, Salles G.
Hematol Oncol. 2023 Jun;41 Suppl 1(Suppl 1):112-118. doi: 10.1002/hon.3153.
Central nervous system prophylaxis in diffuse large B-cell lymphoma.
Zahid MF, Khan N, Hashmi SK, Kizilbash SH, Barta SK.
Eur J Haematol. 2016 Aug;97(2):108-20. doi: 10.1111/ejh.12763. Epub 2016 May 25.
Ibrutinib in primary central nervous system diffuse large B-cell lymphoma.
T Low J, B Peters K.
CNS Oncol. 2020 Mar 1;9(1):CNS51. doi: 10.2217/cns-2019-0022. Epub 2020 Mar 6.
The genomic and transcriptional landscape of primary central nervous system lymphoma.
Radke J, Ishaque N, Koll R, Gu Z, Schumann E, Sieverling L, Uhrig S, Hübschmann D, Toprak UH, López C, Hostench XP, Borgoni S, Juraeva D, Pritsch F, Paramasivam N, Balasubramanian GP, Schlesner M, Sahay S, Weniger M, Pehl D, Radbruch H, Osterloh A, Korfel A, Misch M, Onken J, Faust K, Vajkoczy P, Moskopp D, Wang Y, Jödicke A, Trümper L, Anagnostopoulos I, Lenze D, Küppers R, Hummel M, Schmitt CA, Wiestler OD, Wolf S, Unterberg A, Eils R, Herold-Mende C, Brors B; ICGC MMML-Seq Consortium; Siebert R, Wiemann S, Heppner FL.
Nat Commun. 2022 May 10;13(1):2558. doi: 10.1038/s41467-022-30050-y.
Diffuse large B-cell lymphoma involving the central nervous system: biologic rationale for targeted therapy.
Roschewski M, Hodson DJ.
Haematologica. 2024 Feb 1;109(2):388-400. doi: 10.3324/haematol.2021.278613.
Advances in risk assessment and prophylaxis for central nervous system relapse in diffuse large B-cell lymphoma.
Qualls D, Abramson JS.
Haematologica. 2019 Jan;104(1):25-34. doi: 10.3324/haematol.2018.195834. Epub 2018 Dec 20.
Molecular and clinical diversity in primary central nervous system lymphoma.
Hernández-Verdin I, Kirasic E, Wienand K, Mokhtari K, Eimer S, Loiseau H, Rousseau A, Paillassa J, Ahle G, Lerintiu F, Uro-Coste E, Oberic L, Figarella-Branger D, Chinot O, Gauchotte G, Taillandier L, Marolleau JP, Polivka M, Adam C, Ursu R, Schmitt A, Barillot N, Nichelli L, Lozano-Sánchez F, Ibañez-Juliá MJ, Peyre M, Mathon B, Abada Y, Charlotte F, Davi F, Stewart C, de Reyniès A, Choquet S, Soussain C, Houillier C, Chapuy B, Hoang-Xuan K, Alentorn A.
Ann Oncol. 2023 Feb;34(2):186-199. doi: 10.1016/j.annonc.2022.11.002. Epub 2022 Nov 17.
